Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level

Mol Cell Biol. 1993 Jan;13(1):276-88. doi: 10.1128/mcb.13.1.276-288.1993.

Abstract

Interleukin-6 (IL-6) is known to be a major mediator of the acute-phase response in liver. We show here that IL-6 triggers the rapid activation of a nuclear factor, termed acute-phase response factor (APRF), both in rat liver in vivo and in human hepatoma (HepG2) cells in vitro. APRF bound to IL-6 response elements in the 5'-flanking regions of various acute-phase protein genes (e.g., the alpha 2-macroglobulin, fibrinogen, and alpha 1-acid glycoprotein genes). These elements contain a characteristic hexanucleotide motif, CTGGGA, known to be required for the IL-6 responsiveness of these genes. Analysis of the binding specificity of APRF revealed that it is different from NF-IL6 and NF-kappa B, transcription factors known to be regulated by cytokines and involved in the transcriptional regulation of acute-phase protein genes. In HepG2 cells, activation of APRF was observed within minutes after stimulation with IL-6 or leukemia-inhibitory factor and did not require ongoing protein synthesis. Therefore, a preexisting inactive form of APRF is activated by a posttranslational mechanism. We present evidence that this activation occurs in the cytoplasm and that a phosphorylation is involved. These results lead to the conclusions that APRF is an immediate target of the IL-6 signalling cascade and is likely to play a central role in the transcriptional regulation of many IL-6-induced genes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins / genetics*
  • Acute-Phase Reaction*
  • Animals
  • Base Sequence
  • Binding Sites
  • Consensus Sequence
  • Cytosol / metabolism
  • DNA-Binding Proteins / metabolism*
  • DNA-Binding Proteins / physiology*
  • Gene Expression Regulation / drug effects*
  • Growth Inhibitors / pharmacology
  • In Vitro Techniques
  • Interleukin-1 / pharmacology
  • Interleukin-6 / pharmacology*
  • Leukemia Inhibitory Factor
  • Lipopolysaccharides / pharmacology
  • Lymphokines / pharmacology
  • Male
  • Molecular Sequence Data
  • Molecular Weight
  • Nuclear Proteins / metabolism*
  • Oligodeoxyribonucleotides / chemistry
  • Promoter Regions, Genetic*
  • Rats
  • Rats, Sprague-Dawley
  • STAT3 Transcription Factor
  • Trans-Activators*
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology
  • alpha-Macroglobulins / genetics

Substances

  • Acute-Phase Proteins
  • DNA-Binding Proteins
  • Growth Inhibitors
  • Interleukin-1
  • Interleukin-6
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • Lipopolysaccharides
  • Lymphokines
  • Nuclear Proteins
  • Oligodeoxyribonucleotides
  • STAT3 Transcription Factor
  • Stat3 protein, rat
  • Trans-Activators
  • Tumor Necrosis Factor-alpha
  • alpha-Macroglobulins